Third Harmonic Bio

About:

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

Website: https://www.thirdharmonicbio.com

Twitter/X: 3rdHarmonicBio

Top Investors: General Atlantic, OrbiMed, RA Capital Management, Ajax Health, RTW Investments

Description:

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor for treatment of severe allergy and inflammation. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the body’s interfaces with the external environment and that act as the key mediator of the inflammation associated with allergic diseases.